SLC6A3 and Behcet disease: We previously demonstrated that mice with reduced expression of the dopamine transporter (DAT) exhibit deficient decision-making in the IGT as seen in people with BD, i.e., elevated overall risk preference driven by more frequent choice of risky options following receipt of small, high-probability rewards (elevated safe win-stay) [18].